logo

Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full arti[...]
The days of using one PSA threshold to trigger a biopsy for all men are over, and the field has moved toward a more individualized approach to prostate biopsy decisions, taking int[...]
Improving Multivariable Prostate Cancer Risk Assessment Using The Prostate Health Index Robert W. Foley*†, Laura Gorman*, Neda Sharifi‡, Keefe Murphy§¶, Helen Moore‡, Alexandra V. T[...]
Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
Yet more evidence that the PHI consistently outperforms PSA across diverse populations The Prostate Health Index (PHI) has regulatory approval in >50 countries worldwide and is [...]
Clinical performance of Prostate Health Index (PHI) for prediction of prostate cancer in obese men: data from a multicenter European prospective study, PROMEtheuS project Alberto A[...]